Literature DB >> 32561851

NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity.

Nasir Haider1,2, Previn Dutt2, Bert van de Kooij3, Jason Ho2, Luis Palomero4, Miquel Angel Pujana4, Michael Yaffe3,5, Vuk Stambolic6,7.   

Abstract

In response to genotoxic stress, multiple kinase signaling cascades are activated, many of them directed towards the tumor suppressor p53, which coordinates the DNA damage response (DDR). Defects in DDR pathways lead to an accumulation of mutations that can promote tumorigenesis. Emerging evidence implicates multiple members of the NimA-related kinase (NEK) family (NEK1, NEK10, and NEK11) in the DDR. Here, we describe a function for NEK10 in the regulation of p53 transcriptional activity through tyrosine phosphorylation. NEK10 loss increases cellular proliferation by modulating the p53-dependent transcriptional output. NEK10 directly phosphorylates p53 on Y327, revealing NEK10's unexpected substrate specificity. A p53 mutant at this site (Y327F) acts as a hypomorph, causing an attenuated p53-mediated transcriptional response. Consistently, NEK10-deficient cells display heightened sensitivity to DNA-damaging agents. Further, a combinatorial score of NEK10 and TP53-target gene expression is an independent predictor of a favorable outcome in breast cancers.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32561851     DOI: 10.1038/s41388-020-1361-x

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

Review 1.  Coping with stress: multiple ways to activate p53.

Authors:  H F Horn; K H Vousden
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

Review 2.  Transcriptional control of human p53-regulated genes.

Authors:  Todd Riley; Eduardo Sontag; Patricia Chen; Arnold Levine
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

3.  Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest.

Authors:  L C Huang; K C Clarkin; G M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 4.  Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.

Authors:  Nicholas McGranahan; Charles Swanton
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 5.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

6.  p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.

Authors:  Kyrie Pappas; Jia Xu; Sakellarios Zairis; Lois Resnick-Silverman; Francesco Abate; Nicole Steinbach; Sait Ozturk; Lao H Saal; Tao Su; Pamela Cheung; Hank Schmidt; Stuart Aaronson; Hanina Hibshoosh; James Manfredi; Raul Rabadan; Ramon Parsons
Journal:  Mol Cancer Res       Date:  2017-05-08       Impact factor: 5.852

7.  Li-fraumeni syndrome.

Authors:  David Malkin
Journal:  Genes Cancer       Date:  2011-04

Review 8.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 9.  The multiple mechanisms that regulate p53 activity and cell fate.

Authors:  Antonina Hafner; Martha L Bulyk; Ashwini Jambhekar; Galit Lahav
Journal:  Nat Rev Mol Cell Biol       Date:  2019-04       Impact factor: 94.444

Review 10.  Putting p53 in Context.

Authors:  Edward R Kastenhuber; Scott W Lowe
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582

View more
  8 in total

1.  Genetic colocalization atlas points to common regulatory sites and genes for hematopoietic traits and hematopoietic contributions to disease phenotypes.

Authors:  Christopher S Thom; Benjamin F Voight
Journal:  BMC Med Genomics       Date:  2020-06-29       Impact factor: 3.063

Review 2.  On Broken Ne(c)ks and Broken DNA: The Role of Human NEKs in the DNA Damage Response.

Authors:  Isadora Carolina Betim Pavan; Andressa Peres de Oliveira; Pedro Rafael Firmino Dias; Fernanda Luisa Basei; Luidy Kazuo Issayama; Camila de Castro Ferezin; Fernando Riback Silva; Ana Luisa Rodrigues de Oliveira; Lívia Alves Dos Reis Moura; Mariana Bonjiorno Martins; Fernando Moreira Simabuco; Jörg Kobarg
Journal:  Cells       Date:  2021-02-27       Impact factor: 6.600

3.  Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer.

Authors:  Gangga Anuraga; Wei-Jan Wang; Nam Nhut Phan; Nu Thuy An Ton; Hoang Dang Khoa Ta; Fidelia Berenice Prayugo; Do Thi Minh Xuan; Su-Chi Ku; Yung-Fu Wu; Vivin Andriani; Muhammad Athoillah; Kuen-Haur Lee; Chih-Yang Wang
Journal:  J Pers Med       Date:  2021-10-26

Review 4.  In Mitosis You Are Not: The NIMA Family of Kinases in Aspergillus, Yeast, and Mammals.

Authors:  Scott Bachus; Drayson Graves; Lauren Fulham; Nikolas Akkerman; Caelan Stephanson; Jessica Shieh; Peter Pelka
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

5.  Metabolic heterogeneity protects metastatic mucosal melanomas cells from ferroptosis.

Authors:  Weifan Lin; Xiangwan Lu; Hang Yang; Linxuan Huang; Wuheng Huang; Yuluan Tang; Situn Liu; Hua Wang; Yan Zhang
Journal:  Int J Mol Med       Date:  2022-08-25       Impact factor: 5.314

6.  Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Khadeja-Tul Kubra; Nektarios Barabutis
Journal:  Tissue Barriers       Date:  2021-06-20

7.  Analysis of the effect of NEKs on the prognosis of patients with non-small-cell lung carcinoma based on bioinformatics.

Authors:  Mengxia Yang; Yikun Guo; Xiaofei Guo; Yun Mao; Shijie Zhu; Ningjun Wang; Dianrong Lu
Journal:  Sci Rep       Date:  2022-02-01       Impact factor: 4.996

8.  Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in glioma.

Authors:  Meng Xiao; Chaoyang Du; Chuanbo Zhang; Xinzhong Zhang; Shaomin Li; Dainan Zhang; Wang Jia
Journal:  J Cell Mol Med       Date:  2021-08-10       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.